Literature DB >> 24328927

Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.

Jemila C Kester1, Sarah M Fortune.   

Abstract

One of the challenges in clinical infectious diseases is the problem of chronic infections, which can require long durations of antibiotic treatment and often recur. An emerging explanation for the refractoriness of some infections to treatment is the existence of subpopulations of drug tolerant cells. While typically discussed as "persister" cells, it is becoming increasingly clear that there is significant heterogeneity in drug responses within a bacterial population and that multiple mechanisms underlie the emergence of drug tolerant and drug-resistant subpopulations. Many of these parallel mechanisms have been shown to affect drug susceptibility at the level of a whole population. Here we review mechanisms of phenotypic drug tolerance and resistance in bacteria with the goal of providing a framework for understanding the similarities and differences in these cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24328927     DOI: 10.3109/10409238.2013.869543

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  67 in total

Review 1.  Shelter in a Swarm.

Authors:  Rasika M Harshey; Jonathan D Partridge
Journal:  J Mol Biol       Date:  2015-08-12       Impact factor: 5.469

2.  Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS).

Authors:  Miki Matsuo; Miyu Hiramatsu; Madhuri Singh; Takashi Sasaki; Tomomi Hishinuma; Norio Yamamoto; Yuh Morimoto; Teruo Kirikae; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 3.  Metabolic Perspectives on Persistence.

Authors:  Travis E Hartman; Zhe Wang; Robert S Jansen; Susana Gardete; Kyu Y Rhee
Journal:  Microbiol Spectr       Date:  2017-01

Review 4.  Heterogeneity in tuberculosis.

Authors:  Anthony M Cadena; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Rev Immunol       Date:  2017-07-24       Impact factor: 53.106

5.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

Review 6.  Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa.

Authors:  Donghoon Kang; Natalia V Kirienko
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

Review 7.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

8.  Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.

Authors:  Alan R Hauser; Joan Mecsas; Donald T Moir
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

9.  Temporal and intrinsic factors of rifampicin tolerance in mycobacteria.

Authors:  Kirill Richardson; Owen T Bennion; Shumin Tan; Anh N Hoang; Murat Cokol; Bree B Aldridge
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-29       Impact factor: 11.205

10.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.